Eagle Pharmaceuticals to Present at the 38th Annual J.P. Morgan Healthcare Conference
December 23, 2019WOODCLIFF LAKE, N.J.–(BUSINESS WIRE)–Eagle Pharmaceuticals, Inc. (Nasdaq:EGRX) (“Eagle” or the “Company”) today announced that Scott Tarriff, Chief Executive Officer, and Pete Meyers, Chief Financial Officer, will present at the 38th Annual J.P. Morgan Healthcare Conference as follows:
|
Date: |
Wednesday, January 15, 2020 |
|
|||||
|
Time: |
4:00 p.m. Pacific Standard Time |
|
|||||
|
Location: |
Westin St. Francis Hotel, San Francisco |
|
|||||
|
Webcast: |
https://jpmorgan.metameetings.net/events/hc20/sessions/29767-eagle-pharmaceuticals/webcast |
|
The presentation will be webcast live at the aforementioned time, and archived for 30 days thereafter, via the Company’s website at www.eagleus.com, under the Investors Section.
About Eagle Pharmaceuticals, Inc.
Eagle is a specialty pharmaceutical company focused on developing and commercializing innovative and differentiated injectable products that address the shortcomings, as identified by physicians, pharmacists and other stakeholders, of existing commercially successful injectable products. Additional information is available on the Company’s website at www.eagleus.com.
Contacts
Investor Relations for Eagle Pharmaceuticals, Inc.:
Lisa M. Wilson
In-Site Communications, Inc.
T: 212-452-2793
E: [email protected]